

Sections
Services
Highlight
Pau Sellés
Alicante
Martes, 4 de febrero 2025, 11:41
The Inflammatory Bowel Disease (IBD) Unit at the Sant Joan d'Alacant University Hospital has been accredited with the level of excellence by GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis). This recognition endorses the team's commitment to quality care, comprehensive patient attention, and the implementation of the highest standards in managing this chronic condition.
The manager of the Sant Joan d'Alacant University Hospital, Juan Antonio Marqués, highlighted during the accreditation ceremony that "this achievement reflects the professionalism and dedication of the service, whose commitment to excellence directly impacts the improvement of our patients' quality of life."
Sandra López Pomares, territorial secretary of the Health Department, was responsible for closing the event, which was also attended by Amparo Valladares, manager of healthcare management and institutional relations at ABBVIE; José Ramón García, president of the ACCU Patients Association of Valencia, and Ana Gutiérrez, former president of GETECCU.
In turn, the head of the Digestive Medicine Service at Sant Joan d'Alacant Hospital, Antonio Martínez Egea, emphasized that "this certificate represents recognition of a continuous effort of fifteen years of teamwork. We treat patients with the uniqueness they deserve, considering that in each of them the evolution of symptoms and therefore the treatment is very variable."
The unit, which treats 1,100 patients, is composed of, in addition to Antonio Martínez Egea, head of the Digestive Medicine Service, doctors Gloria García del Castillo, Raquel Laveda, and Nectalí Moya, and nurse Paz Carmona. Furthermore, there is multidisciplinary collaboration with professionals from Surgery, Dermatology, Rheumatology, UIE, Preventive Medicine, Pharmacy, and Radiology.
One of the unit's patients also gave a valuable testimony, recounting how personalized treatment and care since being diagnosed with the disease at age 15 now allows him, at 29, to have achieved control of his condition.
To obtain this accreditation, the unit has met a total of 67 indicators, including personalized follow-up, multidisciplinary approach, continuous training and updating, research and participation in clinical trials, and patient satisfaction with the care received.
IBD primarily encompasses two chronic conditions: Crohn's disease and ulcerative colitis. These conditions affect the gastrointestinal tract, causing symptoms such as abdominal pain, persistent diarrhea, fatigue, and weight loss. Although their exact cause is not fully understood, they are associated with a combination of genetic, immunological, and environmental factors.
It is estimated that between 0.3% and 0.5% of the global population suffers from some form of IBD, and its incidence has been increasing in recent years, highlighting the importance of having specialized units for its diagnosis and treatment.
Publicidad
Publicidad
Te puede interesar
Publicidad
Publicidad
Esta funcionalidad es exclusiva para registrados.
Reporta un error en esta noticia
Comentar es una ventaja exclusiva para registrados
¿Ya eres registrado?
Inicia sesiónNecesitas ser suscriptor para poder votar.